Rockwell Medical reiterated Buy at Summer Street


The note from analyst Carol Werther comes after the PRIME study was selected as best abstract for the 34th Annual Dialysis Conference.

"This is the second time the PRIME data has been peer reviewed at a medical meeting. Triferic reduces ESA and IV iron use without increasing iron stores. In addition, the registrational CRUISE trials have demonstrated that Triferic is safe and effective in ESRD without increased iron stores. The most common reason patients have inadequate response to ESAs is decreased iron availability whether it is absolute or functional iron deficiency (FID). Hyporesponders cause considerable expense in both ESA and IV iron administration. In the bundled era, providers would benefit from using Triferic."

The stock is reaffirmed a Buy with $25 price target.

RMTI +8.5%

From other sites
Comments (3)
  • Stephen Tips
    , contributor
    Comments (629) | Send Message
     
    I was under the impression that " . . . final Phase 3 study and the two CRUISE clinical efficacy and safety studies were conducted in support of the New Drug Application (NDA) for marketing approval of Triferic."

     

    Read more: http://bit.ly/1lL5GYK

     

    This should pop fairly quickly now.

     

    Long RMTI
    13 Feb 2014, 04:02 PM Reply Like
  • smallcap sleuth
    , contributor
    Comments (195) | Send Message
     
    Also long, was very concerned that a head and shoulders pattern had formed and the stock was going to crater. Bought more on the action, been following this for a LONG time. Lived thrust the bear raid spook out that took it down a while back. Hopefully clear sailing to higher heights
    14 Feb 2014, 03:17 AM Reply Like
  • smallcap sleuth
    , contributor
    Comments (195) | Send Message
     
    Once they get approval it should be a short duration until the easy penetration of the 7 if I remember correctly companies that control the dialysis market. Really only 2 majors in the USA. the co already sells to all of the above, its a dollars and cents decision and good for the patients.
    Can someone post the research report from Summer Street? I'd like to see it!
    14 Feb 2014, 03:23 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs